Effects of Intranasal Nerve Growth Factor for Traumatic Brain Injury

Clinical trial NCT01212679 · COMPLETED

Trial details

NCT number: NCT01212679
Sponsor: Jinling Hospital, China
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Traumatic Brain Injury

Start date: 2010-12-01
Primary completion: 2017-10-01
Enrollment: 106

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.